In skincare news that will be sure to cause a buzz in the Philippine regenerative aesthetics scene, Avignon Clinic and Galderma, a global leader in dermatology and aesthetics, announce a strategic ...

AVIGNON Clinic and Galderma, a global leader in dermatology and aesthetics, announce a strategic partnership, aimed at advancing the standard of injectable treatments in the country. The partnership ...

Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment A ...

On Friday, Kepler Cheuvreux analysts initiated coverage on Galderma Group AG (GALD:SW) stock with a Buy rating. The analysts set a price target of CHF137.00, highlighting the company’s promising ...

HOUSTON — Funeral services for Uria Dean Sparks, 90, of Houston, formerly of Longview, will be held at 11:00 a.m. Saturday, May 24, 2025 at Jerusalem Missionary Baptist Church, Longview.

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic dermatitis. The ARCADIA long-term extension (LTE) study has been evaluating ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 2.38 million shares at a price of CHF 97.75 per share for a total consideration of ...

5,11,15 About nemolizumab Nemolizumab was initially developed by Chugai Pharmaceutical Co., Ltd. In 2016, Galderma obtained exclusive rights to the development and marketing of nemolizumab ...

ZUG, Switzerland, June 06, 2025--Galderma (SIX: GALD) today announced two-year data from a new interim analysis of a long-term extension study investigating the safety and efficacy of Nemluvio in ...